"Younger women generally have a higher risk of recurrence than older postmenopausal women, but most studies on anti-hormonal therapy have mainly included postmenopausal women. We therefore wanted to compare the long-term benefit from the treatment in both groups," says Linda Lindstrom, assoc
Bristol [UK], February 5 (ANI): A recent study has found that high doses of a widely-used drug used in the hormonal treatment of conditions like excessive hair growth, early puberty, prostate cancer, are linked to an increased risk of meningioma -- the most common type of benign brain tumour
Washington D.C. [USA], Mar 18 (ANI): According to a recent study, men who receive anti-hormonal treatment after having their prostate removed are 80% more likely to suffer from depression than men who don't receive this treatment.